
ALT Immunohistochemistry-assisted LA-ICP-MS for the Determination of Cancer Biomarkers INTRODUCTION Breast cancer is one of the leading causes of cancer death among women worldwide. Advances in molecular biology have allowed for the discovery of biomarkers that have the potential to provide valuable diagnostic and prognostic information on cases of breast cancer. Progesterone receptors, oestrogen receptors, and HER2, are the main biomarkers used in diagnosis of breast cancer (1). As the value of these three biomarkers is well understood, this research aims to analyse of two biomolecules which may have potential as biomarkers for metastasis progression in breast cancer, MMP-11 and CD45. To accomplish quantitative imaging of these biomolecules, this research employs immuno – mass spectrometry imaging (iMSI), a combination of modified immunohistochemical staining and LA-ICP-MS imaging (2).


